NGLFINE.BO - NGL Fine-Chem Limited

BSE - BSE Real Time Price. Currency in INR

NGL Fine-Chem Limited

301, E Square
Subhash Road Vile Parle (East)
Mumbai 400057
91 22 4084 2222

IndustryDrug Manufacturers—General
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Rahul Jayant NachaneCEO, MD, Chief Ethics Counsellor & Exec. Director26.69MN/A1964
Mr. Rajesh Narayan LawandeWhole Time Director & CFO26.55MN/A1976
Mr. Ahaan NachaneVPN/AN/AN/A
Ms. Pallavi PednekarCompany Sec. & Compliance OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.


NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, and marbofloxacin for animal health applications; and nitazoxanide, atovaquone, and ranolazine for human health applications. The company also provides various intermediate products; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

Corporate Governance

NGL Fine-Chem Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.